Nicholas J Short Selected Research

B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

1/2024	Cost Effectiveness of Zanubrutinib Versus Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
12/2021	Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
1/2020	Risk of Infection Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
9/2018	Infection with ibrutinib in patients with chronic lymphocytic leukemia: How strong is the association?
11/2015	Fludarabine, cyclophosphamide, and multiple-dose rituximab as frontline therapy for chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas J Short Research Topics

Disease

65	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2024 - 11/2015
57	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2024 - 12/2016
49	Philadelphia Chromosome 05/2024 - 12/2016
14	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2024 - 11/2017
14	Neoplasms (Cancer) 02/2024 - 01/2014
13	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2024 - 11/2015
11	Leukemia 05/2024 - 12/2017
8	Infections 01/2023 - 01/2018
8	Residual Neoplasm 12/2022 - 01/2016
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024 - 11/2015
5	Blast Crisis (Blast Phase) 01/2023 - 12/2017
5	Chromosome Aberrations (Chromosome Abnormalities) 01/2023 - 03/2017
4	Hypertension (High Blood Pressure) 01/2023 - 12/2018
4	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023 - 01/2017
4	Thrombocytopenia (Thrombopenia) 01/2023 - 01/2016
3	Disease Progression 02/2024 - 03/2018
3	Exanthema (Rash) 01/2023 - 11/2017
3	Central Nervous System Diseases (CNS Diseases) 12/2022 - 10/2021
3	Pathologic Complete Response 07/2020 - 12/2018
2	Neutropenia 04/2024 - 01/2021
2	Myocardial Infarction 01/2023 - 12/2018
2	Hemorrhage 01/2023 - 12/2018
2	Pancreatitis 01/2023 - 12/2018
2	Cytokine Release Syndrome 12/2022 - 12/2017
2	Hyperbilirubinemia 01/2022 - 11/2017
2	Cytopenia 01/2021 - 01/2020
2	Dehydration (Water Stress) 11/2008 - 06/2007
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024
1	Turcot syndrome 03/2024
1	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2024
1	Monosomy 03/2023
1	monosomy Chromosome 7 03/2023
1	Tremor (Tremors) 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Pain (Aches) 01/2023
1	Anemia 01/2023

Drug/Important Bio-Agent (IBA)

35	venetoclaxIBA 04/2024 - 01/2020
30	Tyrosine Kinase InhibitorsIBA 05/2024 - 01/2016
18	blinatumomabIBA 01/2024 - 12/2017
15	ponatinibIBA 05/2024 - 12/2016
13	Decitabine FDA Link 02/2024 - 01/2017
12	Inotuzumab OzogamicinIBA 05/2024 - 01/2018
9	Azacitidine (5 Azacytidine)FDA Link 02/2024 - 01/2017
7	Dasatinib (BMS 354825)FDA Link 04/2024 - 12/2016
7	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 01/2016
7	Vincristine (Oncovin)FDA LinkGeneric 10/2021 - 01/2016
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021 - 11/2015
5	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021 - 01/2016
5	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 01/2016
4	Transaminases (Aminotransferases)IBA 01/2023 - 11/2017
4	fms-Like Tyrosine Kinase 3IBA 01/2022 - 01/2019
3	ibrutinibIBA 01/2024 - 09/2018
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 01/2021
3	Rituximab (Mabthera)FDA Link 10/2021 - 11/2015
3	fludarabineIBA 01/2018 - 11/2015
2	Imatinib Mesylate (Gleevec)FDA Link 12/2023 - 01/2020
2	NucleophosminIBA 01/2023 - 12/2020
2	BilirubinIBA 01/2023 - 12/2018
2	EnzymesIBA 01/2023 - 01/2023
2	Lysine (L-Lysine)FDA Link 01/2023 - 01/2021
2	MethyltransferasesIBA 01/2023 - 01/2021
2	enasidenibIBA 01/2023 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2017
2	AnthracyclinesIBA 05/2022 - 01/2016
2	CreatinineIBA 01/2022 - 12/2018
2	bcr-abl Fusion ProteinsIBA 01/2022 - 01/2020
2	ofatumumab FDA Link 01/2021 - 07/2020
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2018 - 11/2017
2	Clofarabine (Clolar)FDA Link 01/2018 - 11/2017
2	Purine NucleosidesIBA 01/2018 - 11/2017
1	Immunoconjugates (Immunoconjugate)IBA 05/2024
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2024
1	NivolumabIBA 02/2024
1	Alkylating AgentsIBA 02/2024
1	cedazuridineIBA 02/2024
1	zanubrutinibIBA 01/2024
1	RNA Splicing FactorsIBA 11/2023
1	PLX51107IBA 11/2023
1	nuclear pore complex protein 98IBA 03/2023
1	pevonedistatIBA 01/2023
1	Amylases FDA Link 01/2023
1	milademetanIBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	isocitric acid (isocitrate)IBA 01/2023
1	Alanine Transaminase (SGPT)IBA 01/2023
1	Lipase (Acid Lipase)FDA Link 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	ivosidenibIBA 01/2023

Therapy/Procedure

52	Drug Therapy (Chemotherapy) 01/2024 - 01/2016
47	Therapeutics 04/2024 - 11/2015
8	Stem Cell Transplantation 01/2024 - 01/2016
4	Salvage Therapy 01/2023 - 01/2020
4	Induction Chemotherapy 01/2022 - 01/2016
3	Hematopoietic Stem Cell Transplantation 02/2024 - 01/2018
3	Consolidation Chemotherapy 12/2022 - 01/2018
2	Radiotherapy 12/2022 - 01/2020
2	Immunotherapy 01/2022 - 01/2020
1	Bariatric Surgery 01/2023